213 related articles for article (PubMed ID: 22923147)
41. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
[TBL] [Abstract][Full Text] [Related]
42. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.
Sivera R; Martín N; Boscá I; Sevilla T; Muelas N; Azorín I; Vílchez JJ; Bolonio M; Donat E; Ribes-Koninckx C; Bataller L
J Neurol; 2012 May; 259(5):851-4. PubMed ID: 21984193
[TBL] [Abstract][Full Text] [Related]
43. Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus.
Folli F; Daniele G; Werner S; Kamath S; Munera JV; Abboud H; Fanti P
Acta Diabetol; 2015 Oct; 52(5):897-903. PubMed ID: 25753172
[TBL] [Abstract][Full Text] [Related]
44. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
[TBL] [Abstract][Full Text] [Related]
45. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
46. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.
Rakocevic G; Raju R; Semino-Mora C; Dalakas MC
Neurology; 2006 Sep; 67(6):1068-70. PubMed ID: 17000981
[TBL] [Abstract][Full Text] [Related]
47. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
[TBL] [Abstract][Full Text] [Related]
48. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
[TBL] [Abstract][Full Text] [Related]
49. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
50. Square-Wave Ocular Oscillation and Ataxia in an Anti-GAD-Positive Individual With Hypothyroidism.
Brokalaki C; Kararizou E; Dimitrakopoulos A; Evdokimidis I; Anagnostou E
J Neuroophthalmol; 2015 Dec; 35(4):390-5. PubMed ID: 26035807
[TBL] [Abstract][Full Text] [Related]
51. "Hot Cross Bun" Sign in a Patient with Glutamic Acid Decarboxylase 65-KDa Isoform Associated Cerebellar Ataxia: Case Report and Review of the Literature.
Duan RN; He JZ; Cao LL
Cerebellum; 2024 Jun; 23(3):1204-1210. PubMed ID: 37948023
[TBL] [Abstract][Full Text] [Related]
52. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
53. [Autoantibodies to GAD and autoimmune-mediated neurological diseases].
Mitoma H; Mizusawa H
Nihon Rinsho; 2013 May; 71(5):921-6. PubMed ID: 23777105
[TBL] [Abstract][Full Text] [Related]
54. Anti-GAD antibodies and periodic alternating nystagmus.
Tilikete C; Vighetto A; Trouillas P; Honnorat J
Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
[TBL] [Abstract][Full Text] [Related]
55. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
56. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease.
Chang CC; Eggers SD; Johnson JK; Haman A; Miller BL; Geschwind MD
Clin Neurol Neurosurg; 2007 Jan; 109(1):54-7. PubMed ID: 16621241
[TBL] [Abstract][Full Text] [Related]
57. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
[TBL] [Abstract][Full Text] [Related]
58. [Clinical characteristics and prognosis of patients with anti-glutamic acid decarboxylase antibody-related cerebellar ataxia].
Bai L; Cai Y; Ren HT; Di WY; Liu MG; Fan SY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1935-1937. PubMed ID: 35768393
[TBL] [Abstract][Full Text] [Related]
59. Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.
Thaler FS; Thaller AL; Biljecki M; Schuh E; Winklmeier S; Mahler CF; Gerhards R; Völk S; Schnorfeil F; Subklewe M; Hohlfeld R; Kümpfel T; Meinl E
Ann Neurol; 2019 Mar; 85(3):448-454. PubMed ID: 30635933
[TBL] [Abstract][Full Text] [Related]
60. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
